Table Of Contents: Volume 83, Number 51: December 19, 2005

Cover Story
Chemistry Highlights 2005
Key advances have been made this year in organic and inorganic chemistry, biochemistry, nanotechnology, and other areas.
News of the Week
Degussa Readies A Streamlining
Company to reorganize top management, weighs sale of construction chemicals.
DuPont, EPA Settle
Company to pay $16.5 million to settle PFOA allegations.
New Perspective On Reactions
Molecule's point of view reveals much about evolution of molecular dynamics.

Rohm And Haas Restructures In Europe
Firm to realign manufacturing, restructure electronic materials, and shed 400 positions.
BP Admits Safety Lapses
Company will spend $1 billion to improve safety at Texas City refinery after explosion.
Drug Majors Talk To Wall Street
Three firms weigh pipelines, patents, and research in forecasts for growth.
PET Project
Microfluidic device synthesizes medical imaging probe in multistep process.
Business (Suscriber Content)

2005 Year in Review
Industry recovery continued in 2005, but it was hindered by high energy prices and disasters.
Finding Magic In Polymer R&D
Dutch Polymer Institute meeting spotlights research into new technology and applications.
Hovione In Macau
Pharmaceutical ingredient plant is an important part of firm's global network.
Government & Policy (Suscriber Content)

Clashing Over Hazmat Shipping
Banning hazardous materials on certain rail routes would not eliminate risks, industry officials argue.
Crunching Data
NRC panel is studying how EPA should select and use models for regulatory decision.
Science & Technology (Suscriber Content)

Materials Science Blossoms In Boston
Talks feature tooth whitening, electrochromic plastics, smart textiles, and nanoparticle studies.
Science For Peace In The Middle East
Malta conferences encourage stronger scientific ties to counter political strife in troubled region.

The $1,000 Genome
New methods aim to drive cost of sequencing an individual human genome to below $1,000.
Protein Synthesis Nipped In The Bud
Inhibitor of initial step of protein biosynthesis could lead to new anticancer or antiviral drugs.
Digital Briefs
New Software And Websites For The Chemical Enterprise.
Books
Hard Lessons Learned In China
Books on China's business environment abound, but their quality and usefulness are uneven.
ACS News
Editor's Page
The Departments
Current Issue

2005 Chemistry Year In Review
Recent Issues

Chemistry At Play
December 12, 2005
Table of Contents

Pharma Reformulates
December 5, 2005
Table of Contents
